Double blind, randomised, parallel, prospective, comparative, clinical evaluation of a combination of antispasmodic analgesic Diclofenac + Pitofenone + Fenpiverinium (Manyana) vs Analgin + Pitofenone + Fenpiverinium (Baralgan) in biliary, ureteric and intestinal colic

J Indian Med Assoc. 1999 Feb;97(2):72-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Benzophenones / adverse effects
  • Benzophenones / therapeutic use*
  • Biliary Tract Diseases / drug therapy*
  • Biliary Tract Diseases / etiology
  • Colic / drug therapy*
  • Colic / etiology
  • Diclofenac / adverse effects
  • Diclofenac / therapeutic use*
  • Dipyrone / adverse effects
  • Dipyrone / therapeutic use*
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Humans
  • Intestinal Diseases / drug therapy*
  • Intestinal Diseases / etiology
  • Male
  • Middle Aged
  • Pain Measurement
  • Parasympatholytics / adverse effects
  • Parasympatholytics / therapeutic use*
  • Piperidines / adverse effects
  • Piperidines / therapeutic use*
  • Prospective Studies
  • Ureteral Diseases / drug therapy*
  • Ureteral Diseases / etiology

Substances

  • Benzophenones
  • Drug Combinations
  • Parasympatholytics
  • Piperidines
  • manyana
  • Diclofenac
  • Dipyrone
  • fenpiverinium bromide, pitofenone hydrochloride, dipyrone drug combination